Büll U - Search Results

1

[Investigations on the effect of "ecstasy" on cerebral glucose metabolism: an 18-FDG PET study].

Schreckenberger M, Gouzoulis-Mayfrank E, Sabri O, Arning C, Tuttass T, Schulz G, Kaiser HJ, Wagenknecht G, Sass H, Büll U. Schreckenberger M, et al. Among authors: bull u. Nuklearmedizin. 1998;37(8):262-7. Nuklearmedizin. 1998. PMID: 9868707 Clinical Trial. German.

2

[Effect of morphological changes on perfusion and metabolism in cerebral microangiopathy. A comparison of PET, SPECT, and magnetic resonance imaging findings].

Sabri O, Hellwig D, Kaiser HJ, Doherty C, Schneider R, Mull M, Willmes von Hinckeldey KW, Büll U, Thron A, Ringelstein EB. Sabri O, et al. Among authors: bull u. Nuklearmedizin. 1995 Apr;34(2):50-6. Nuklearmedizin. 1995. PMID: 7761273 Clinical Trial. German.

3

A method of correlating and merging cerebral morphology and function by a special head holder.

Kaiser HJ, Sabri O, Wagenknecht G, Lege B, Hellwig D, Büll U. Kaiser HJ, et al. Among authors: bull u. Nuklearmedizin. 1994 Jun;33(3):123-6. Nuklearmedizin. 1994. PMID: 8090627

4

[Comparison of relative 18FDG uptake with metabolic rate (MRGlucose) in the myocardium in CAD, classified by 99m-Tc-MIBI].

Büll U, Foroutan Y, Hellwig D, Kaiser HJ, Schulz G, Sabri O, Schreckenberger M, vom Dahl J. Büll U, et al. Nuklearmedizin. 1995 Dec;34(6):223-8. Nuklearmedizin. 1995. PMID: 8596738 German.

5

[Assessment of myocardial viability using 201TL SPECT at rest to predict the reversibility of left ventricular wall motion abnormalities].

Schulz G, Koch KC, vom Dahl J, Kleinhans E, Kaiser HJ, Verhasselt S, Messmer BJ, Hanrath P, Büll U. Schulz G, et al. Among authors: bull u. Nuklearmedizin. 1996 Dec;35(6):198-204. Nuklearmedizin. 1996. PMID: 8999419 German.

6

[A method for combined scatter and attenuation correction without transmission measurement for myocardial SPECT with 99m-Tc binding].

Kupferschläger J, Müller B, Schulz G, Kaiser HJ, Wagenknecht G, Bares R, Büll U. Kupferschläger J, et al. Among authors: bull u. Nuklearmedizin. 1997 Mar;36(2):56-64. Nuklearmedizin. 1997. PMID: 9148274 German.

7

[Comparison of findings with 18-FDG PET and CT in pretherapeutic staging of malignant lymphoma].

Thill R, Neuerburg J, Fabry U, Cremerius U, Wagenknecht G, Hellwig D, Osieka R, Günther R, Büll U. Thill R, et al. Among authors: bull u. Nuklearmedizin. 1997 Oct;36(7):234-9. Nuklearmedizin. 1997. PMID: 9441282 German.

8

[Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients with Graves' disease].

Sabri O, Schulz G, Zimny M, Schreckenberger M, Zimny D, Wagenknecht G, Kaiser HJ, Dohmen BM, Bares R, Büll U. Sabri O, et al. Among authors: bull u. Nuklearmedizin. 1998 May;37(3):83-9. Nuklearmedizin. 1998. PMID: 9604227 German.

9

[Attenuation corrected myocardial PET after application of 18FDG: effect on the determination of regional myocardial uptake values].

Schulz G, Ostwald E, Schreckenberger M, Sabri O, Müller B, vom Dahl J, Büll U. Schulz G, et al. Among authors: bull u. Nuklearmedizin. 1998 Aug;37(5):166-70. Nuklearmedizin. 1998. PMID: 9728343 German.

10

Neurometabolic effects of psilocybin, 3,4-methylenedioxyethylamphetamine (MDE) and d-methamphetamine in healthy volunteers. A double-blind, placebo-controlled PET study with [18F]FDG.

Gouzoulis-Mayfrank E, Schreckenberger M, Sabri O, Arning C, Thelen B, Spitzer M, Kovar KA, Hermle L, Büll U, Sass H. Gouzoulis-Mayfrank E, et al. Among authors: bull u. Neuropsychopharmacology. 1999 Jun;20(6):565-81. doi: 10.1016/S0893-133X(98)00089-X. Neuropsychopharmacology. 1999. PMID: 10327426 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters